Neogen Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-11-30 was 0.00 shares, a 100.00% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-08-31 was 4.00K shares, a 20.00% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-05-31 was 280.72K shares, a 68.74% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-02-28 was -261.72K shares, a 232.85% decline year-over-year.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 100.00K shares.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- Neogen Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 22.00K shares, a 92.17% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-05-31 | 100.00K shares 10-K · filed 2026-07-30 | |
| 2025-05-31 | 0.00 shares 10-K · filed 2026-07-30 | |
| 2024-05-31 | 0.00 shares 10-K · filed 2026-07-30 | |
| 2023-05-31 | 22.00K shares 10-K · filed 2025-07-30 | |
| 2022-11-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | 23.00K shares derived: sum of 4 quarters · filed 2024-07-30 |
| 2022-08-31 | 4.00K shares 10-Q · filed 2022-09-30 | 280.00K shares derived: sum of 4 quarters · filed 2024-07-30 |
| 2022-05-31 | 280.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | 281.00K shares 10-K · filed 2024-07-30 |
| 2022-02-28 | -261.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | 898.28K shares derived: sum of 4 quarters · filed 2023-08-15 |
| 2021-11-30 | 257.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | 1.36M shares derived: sum of 4 quarters · filed 2023-08-15 |
| 2021-08-31 | 5.00K shares 10-Q · filed 2021-09-30 | 1.31M shares derived: sum of 4 quarters · filed 2023-08-15 |
| 2021-05-31 | 898.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | 1.39M shares 10-K · filed 2023-08-15 |
| 2021-02-28 | 197.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | 1.24M shares derived: sum of 4 quarters · filed 2022-07-27 |
| 2020-11-30 | 208.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | 1.24M shares derived: sum of 4 quarters · filed 2022-07-27 |
| 2020-08-31 | 86.00K shares 10-Q · filed 2020-09-30 | 1.33M shares derived: sum of 4 quarters · filed 2022-07-27 |
| 2020-05-31 | 752.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | 1.44M shares 10-K · filed 2022-07-27 |
| 2020-02-29 | 193.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -416.89M shares derived: sum of 4 quarters · filed 2021-07-30 |
| 2019-11-30 | 297.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | -338.50M shares derived: sum of 4 quarters · filed 2021-07-30 |
| 2019-08-31 | 196.00K shares 10-Q · filed 2019-09-26 | -251.85M shares derived: sum of 4 quarters · filed 2021-07-30 |
| 2019-05-31 | -417.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | 1.03M shares 10-K · filed 2021-07-30 |
| 2019-02-28 | 78.58M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | 418.75M shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-11-30 | 86.95M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | 340.24M shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-08-31 | 253.08M shares 10-Q · filed 2018-10-05 | 253.85M shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2018-05-31 | 153.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | 821.00K shares 10-K · filed 2020-07-30 |
| 2018-02-28 | 65.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | 953.00K shares derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-11-30 | 557.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | 1.03M shares derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-08-31 | 46.00K shares 10-Q · filed 2017-09-29 | 737.00K shares derived: sum of 4 quarters · filed 2019-07-30 |
| 2017-05-31 | 285.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | 827.00K shares 10-K · filed 2019-07-30 |
| 2017-02-28 | 139.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | 726.00K shares derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-11-30 | 267.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | 657.00K shares derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-08-31 | 136.00K shares 10-Q · filed 2016-09-30 | 460.00K shares derived: sum of 4 quarters · filed 2018-07-27 |
| 2016-05-31 | 184.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | 569.00K shares 10-K · filed 2018-07-27 |
| 2016-02-29 | 70.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | 470.00K shares derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-11-30 | 70.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | 474.00K shares derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-08-31 | 245.00K shares 10-Q · filed 2015-09-30 | 434.00K shares derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-05-31 | 85.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | 380.00K shares 10-K · filed 2017-07-28 |
| 2015-02-28 | 74.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | 382.00K shares derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-11-30 | 30.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | |
| 2014-08-31 | 191.00K shares 10-Q · filed 2014-09-30 | |
| 2014-05-31 | 87.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | 643.00K shares 10-K · filed 2016-07-29 |
| 2013-08-31 | 182.00K shares 10-Q · filed 2013-09-30 | 656.00K shares derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | 355.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | 657.00K shares 10-K · filed 2015-07-30 |
| 2013-02-28 | 67.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | 533.00K shares derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | 52.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | 486.00K shares derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | 183.00K shares 10-Q · filed 2012-09-28 | 586.00K shares derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | 231.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | 480.00K shares 10-K · filed 2014-07-30 |
| 2012-02-29 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | |
| 2011-11-30 | 152.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | |
| 2011-08-31 | 77.00K shares 10-Q · filed 2011-09-30 | |
| 2011-05-31 | 627.00K shares 10-K · filed 2013-07-30 | |
| 2010-05-31 | 480.00K shares 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |